Many studies that have investigated genetic modifiers in LRRK2-associated parkinsonism did not account for underlying pathology.5,50,62 In future studies, stratification of manifest cases according to evidence of asyn aggregates may yield new insights. This evidence concerns the gene LRRK2 and Parkinson disease.